UCSF

2005 News

A research collaboration between the University of California (UC) and Peking University will integrate the biological data acquisition strengths of the former with the physical and theoretical strengths of the latter, a move which scientists anticipate will ultimately lead to more effective, safer medications for populations and individuals.
Kathy M. Giacomini, PhD
Kathy M. Giacomini, PhD, UCSF School of Pharmacy scientist, received the 2005 Paul Dawson Biotechnology Award in Cincinnati, Ohio on July 10, 2005 from the American Association of Colleges of Pharmacy (AACP). The award recognizes exceptional teaching and research in biotechnology.
The UCSF School of Pharmacy was the largest recipient of 2004 research funding from the National Institutes of Health (NIH) among pharmacy schools in the United States. The School's 2004 total NIH award funding was US$23.5 million. "The 2004 ranking marks the 25th consecutive year we've received top NIH funding," said Mary Anne Koda-Kimble, PharmD, dean, UCSF School of Pharmacy. The 1979 figure was US$1.7 million. This is quite an accomplishment."
The UCSF School of Pharmacy maintains its ranking as the best doctor of pharmacy degree program in the United States, according to a survey conducted by U.S. News & World Report.
Capitol Building
The Center for Drug Development Science (CDDS), located in Washington, DC, has joined with the UCSF School of Pharmacy to advance the safe and effective use of drugs. CDDS moved its academic affiliation in fall 2004 from Georgetown University to UCSF, while retaining its District of Columbia location at the University of California Washington, DC Center building, just six blocks from the White House.
Special Report / Fall-Winter 2005: An overview of School accomplishments based upon a written report that Dean Mary Anne Koda-Kimble, PharmD submitted to a UCSF faculty committee as part of a review of her performance as dean from 1998 to 2003. Includes updates from 2003 through March 2005. "My first 5 years as dean...and since" and more.